GlassScriptPhysician profile
Arthur D Black
NPI 1316939358
$6,524.37
in general payments reported to CMS, 2019-2025
30 companies · $3,361 in 2025
The $3,361 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $138 · 2021: $21.59 · 2022: $1,324 · 2023: $498 · 2024: $718 · 2025: $3,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $2,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $2,077.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,644.74 | 2022-2025 | |
| Stryker Corporation | $808.92 | 2020-2022 | |
| Sanara Medtech INC. | $364.93 | 2022-2023 | Celleraterx |
| Shoulder Innovations, INC. | $332.07 | 2024 | Inset System |
| Smith+Nephew, INC. | $283.29 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $262.13 | 2019-2025 | Monovisc, Orthovisc |
| Miach Orthopaedics, INC. | $260.61 | 2022 | |
| Alon Medical Technology | $232.64 | 2024-2025 | |
| Ethicon US, LLC | $201.74 | 2025 | Dermabond Prineo, Vistaseal |
| Bioventus LLC | $170.33 | 2019-2024 | Durolane, Durolane, Gelsyn-3 |
| Vertex Pharmaceuticals Incorporated | $159.68 | 2024-2025 | |
| Fidia Pharma USA INC. | $149.11 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $108.10 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $103.38 | 2023 | Oxford, Rosa, Persona |
| Organogenesis INC. | $50.25 | 2024-2025 | Puraply Wound Matrix, Puraply Am |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $47.21 | 2025 | |
| Vericel Corporation | $46.36 | 2024-2025 | Maci |
| Pacira Therapeutics, INC. | $46.29 | 2019 | |
| Djo, LLC | $43.69 | 2024 | Cmf |
| Mallinckrodt Enterprises LLC | $29.25 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $27.81 | 2023 | Exparel, Iovera, Zilretta |
| Orthofix Medical, INC. | $24.35 | 2019-2023 | Physio-Stim |
| Innovation Technologies INC | $20.78 | 2024 | Irrisept |
| Urgo Medical North America, LLC | $20.62 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Orthogenrx INC. | $16.33 | 2019 | |
| Zyla Life Sciences, INC. | $16.03 | 2019 | |
| Pfizer INC. | $14.39 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.53 | 2019 | |
| Medtronic, INC. | $13.28 | 2024 | Intellis Adaptivestim |
| Melinta Therapeutics, LLC | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.